Shih, Terri
Park, Sarah
Thorlacius, Linnea R.
Daveluy, Steven
Garg, Amit
Goegji, Susanne D.
Kirby, Joslyn S.
McGrath, Barry M.
Riis, Peter T.
Villumsen, Bente
Zalik, Kari
Jemec, Gregor B. E.
Hsiao, Jennifer L.
Funding for this research was provided by:
University of Southern California
Article History
Received: 16 July 2022
Revised: 7 December 2022
Accepted: 6 January 2023
First Online: 21 January 2023
Declarations
:
: JLH is on the Board of Directors for the Hidradenitis Suppurativa Foundation, has served as a consultant for Boehringer Ingelheim, Novartis, and UCB, and has served as a consultant and speaker for AbbVie. LT reports personal fees from UCB, non-financial support from AbbVie and Janssen-Cilag, grants from Regeneron, and is co-copyright holder of HiSQOL. SD is on the Board of Directors for the Hidradenitis Suppurativa Foundation, has served as an investigator for AbbVie, Pfizer, Novartis, and UCB, and has served as a consultant and speaker for AbbVie. AG is an advisor for AbbVie, Aclaris Therapeutics, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, InflaRx, Insmed, Janssen, Novartis, Pfizer, UCB, Union Therapeutics, and Viela Biosciences, and receives honoraria. AG receives research grants from AbbVie, UCB and National Psoriasis Foundation. AG receives research grants from AbbVie, UCB, and National Psoriasis Foundation. AG is co-copyright holder of the HS-IGA and HiSQOL instruments. JSK is the President of the Hidradenitis Suppurativa Foundation. AbbVie: Consultant, Speaker, Advisory Board (Honoraria), ChemoCentryx, Incyte, Janssen, Novartis, UCB: Consultant (Honoraria). BMG has received fees from Novartis. GBJ reports grants and personal fees from AbbVie, personal fees from Coloplast, personal fees from Chemocentryx, personal fees from LEO pharma, grants from LEO Foundation, grants from Afyx, personal fees from Incyte, grants and personal fees from InflaRx, grants from Janssen-Cilag, grants and personal fees from Novartis, grants and personal fees from UCB, grants from CSL Behring, grants from Regeneron, grants from Sanofi, personal fees from Kymera, personal fees from VielaBio, outside the submitted work. There was no financial transaction for the preparation of this manuscript. All other authors report no conflicts of interest.